Navigation Links
Certain types of graft-versus-host disease may increase risk of death, Moffitt researcher says
Date:6/17/2013

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-host disease (GVHD) are associated with worsened quality of life and death.

Their study appeared in the May issue of Biology of Blood and Marrow Transplantation, the official journal of the American Society for Blood and Marrow Transplantation.

GVHD is a complication that can occur when a transplant patient receives stem cells or bone marrow from a donor. The transplanted cells regard the recipient's body as foreign and attack, causing symptoms ranging from nausea and skin rashes to fatigue and pain. Patients with GVHD are prescribed drugs to suppress their immune system to counteract the disease.

The researchers studied data from 567 patients to determine if the characteristics and symptoms of chronic GVHD were associated with major clinical outcomes, such as quality of life and death. They looked specifically at the site of gastrointestinal tract involvement and liver abnormalities.

"We found important differences in outcomes in relation to gastrointestinal and liver involvement," Pidala said. "Those with elevated bilirubin (a substance in bile) levels, higher gastrointestinal scores, or lower gastrointestinal involvement had an increased risk of death under current treatment approaches."

The authors concluded that their findings will help physicians better define a patient's risk of complications and death after chronic GVHD diagnosis and treatment.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
2. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
3. Codeine After Surgery Could Endanger Certain Kids: Study
4. Decision guide reduced uncertainty over breast cancer prevention, study finds
5. Certain Genetic Regions May Be Tied to Osteoporosis
6. Hot Flashes More Likely for Certain Smokers, Study Says
7. Early Study Hints at Link Between Certain Sunscreens, Endometriosis
8. Cabazitaxel can offer an advantage in certain patients
9. Antioxidant shows promise as treatment for certain features of autism, Stanford study finds
10. Gout Flare-ups Rise Sharply With Certain Foods: Study
11. Mouse Study Suggests Certain Fats Could Trigger Crohns, Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
Breaking Medicine Technology: